Flourishing demand of Healthcare CRO Services Market Size Over 2026


The global healthcare contract research organization (CRO) services market was valued at $38,996.9 million in 2018 and is expected to reach $66,036.6 million by 2026, registering a CAGR of 6.9% from 2019 to 2026. Contract research organizations (CROs) are outsourcing companies or groups that conduct specific and focused R&D clinical trials for the pharmaceutical or biotech industry. They possess well-experienced professionals that offer preclinical, clinical, and regulatory activities for drug and medical devices development, and their commercialization. These organizations can range from international full-service groups to small or niche service providing groups. In addition, CROs provide the experience of moving a novel drug, molecule, or a drug from its nascent phase to marketing approval, without any involvement of a sponsor for these services.

Some of the key players of Healthcare CRO Services Market:

IQVIA, PRA Health Sciences, ICON, Syneos Health, Evotec, Charles River, Medpace, Labcorp, Biotelemetry, Syngene





Segmentation by Service Type

  • Early Phase Development
  • Clinical Research Services
  • Laboratory Services
  • Consulting Services

Segmentation by Therapeutic Area

  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Metabolic Disease
  • Infectious Disease
  • Diabetes
  • Others

Segmentation by End-User

  • Pharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes


Comments

Popular posts from this blog

Latest Innovation Knocking-in Luxuries Industry

Urgent Care Centers Market

Future Scope for Deep Sea Exploration Robot Industry